Nicole Anders

Research Assoc

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
temozolomide Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Histone Deacetylase Inhibitors Medicine & Life Sciences
Methyltransferases Medicine & Life Sciences
efavirenz Medicine & Life Sciences
Liquid chromatography Chemical Compounds
decitabine Medicine & Life Sciences
Vitis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors

Gaillard, S., Zahurak, M., Sharma, A., Reiss, K. A., Sartorius-Mergenthaler, S., Downs, M., Anders, N., Ahuja, N., Rudek-Renaut, M. & Azad, N., Jan 1 2019, In : Cancer.

Research output: Contribution to journalArticle

Histone Deacetylase Inhibitors
Long Interspersed Nucleotide Elements

Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth

Hoang, T., Zierden, H., Date, A., Ortiz, J., Gumber, S., Anders, N., He, P., Segars, J., Hanes, J. S., Mahendroo, M. & Ensign-Hodges, L., Feb 10 2019, In : Journal of Controlled Release. 295, p. 74-86 13 p.

Research output: Contribution to journalArticle

Premature Birth
Intravaginal Administration
Drug Compounding

Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer

Anchoori, R., Jiang, R., Peng, S., Soong, R. S., Algethami, A., Rudek-Renaut, M., Anders, N., Hung, C-F., Chen, X., Lu, X., Kayode, O., Dyba, M., Walters, K. J. & Roden, R. S., Sep 30 2018, In : ACS Omega. 3, 9, p. 11917-11929 13 p.

Research output: Contribution to journalArticle

Bearings (structural)
Firefly Luciferases

Muscadine grape skin extract (MPX) in men with biochemically recurrent prostate cancer: A randomized, multicenter, placebo-controlled clinical trial

Paller, C., Zhou, X. C., Heath, E. I., Taplin, M. E., Mayer, T., Stein, M. N., Bubley, G. J., Pili, R., Hudson, T., Kakarla, R., Abbas, M. M., Anders, N., Dowling, D., King, S., Bruns, A. B., Wagner, W. D., Drake, C. G., Antonarakis, E., Eisenberger, M., Denmeade, S. R. & 3 othersRudek-Renaut, M., Rosner, G. & Carducci, M. A., Jan 15 2018, In : Clinical Cancer Research. 24, 2, p. 306-315 10 p.

Research output: Contribution to journalArticle

Controlled Clinical Trials
Prostatic Neoplasms

Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer

Converse, P. J., Almeida, D. V., Tasneen, R., Saini, V., Tyagi, S., Ammerman, N., Li, S. Y., Anders, N., Rudek-Renaut, M., Grosset, J. H. & Nuermberger, E., Aug 1 2018, In : PLoS Neglected Tropical Diseases. 12, 8, e0006728.

Research output: Contribution to journalArticle

Mycobacterium ulcerans
Buruli Ulcer